DR. HEATHER M ROWE M.D.
Prescription History 1235172016
Psychiatry & Neurology - Psychiatry in Virginia Beach, VA

NPI Status: Active since June 13, 2006

Contact Information

4854 HAYGOOD RD STE 101
VIRGINIA BEACH, VA
ZIP 23455
Phone: (757) 468-0550
Fax: (757) 468-9992

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. HEATHER M ROWE M.D., an active Psychiatry specialist practicing in Virginia Beach, VA. Our medical registry currently tracks 71 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 8,284 documented patient claims. Among these therapy options, the most frequently utilized medication is Lamotrigine, which accounts for 562 claims alone.


Abilify Maintena

Generic Formulation: AripiprazoleSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 101
30-Day Fills 101.0
Days Supply 2,828
VA State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills26.6
Peer Average Days Supply747
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 288.5% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $249,233.83 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,467.66

State Avg Cost Per Claim

$2,586.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A piperazine and quinolone derivative that is used primarily as an antipsychotic agent. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as an adjunct therapy for the treatment of depression.

Therapeutic Applications

Aripiprazole is used to treat certain mental/mood disorders (such as bipolar disorder, schizophrenia, Tourette's syndrome, and irritability associated with autistic disorder). It may also be used in combination with other medication to treat depression. Aripiprazole is known as an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural chemicals in the brain (neurotransmitters). This medication can decrease hallucinations and improve your concentration. It helps you to think more clearly and positively about yourself, feel less nervous, and take a more active part in everyday life. Aripiprazole can treat severe mood swings and decrease how often mood swings occur.

Alprazolam

Generic Formulation: AlprazolamSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 74
30-Day Fills 74.0
Days Supply 2,125
VA State Average Benchmarks
Peer Average Claims57.0
Peer Average 30-Day Fills63.0
Peer Average Days Supply1,733
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 29.8% more claims than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $310.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.20

State Avg Cost Per Claim

$8.30

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)

Therapeutic Applications

Alprazolam is used to treat anxiety and panic disorders. It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).

Amitriptyline Hcl

Generic Formulation: Amitriptyline HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 39
30-Day Fills 73.0
Days Supply 2,190
VA State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills53.0
Peer Average Days Supply1,577
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 39.3% more claims than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $946.24 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.26

State Avg Cost Per Claim

$21.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat mental/mood problems such as depression. It may help improve mood and feelings of well-being, relieve anxiety and tension, help you sleep better, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters such as serotonin) in the brain.

Aripiprazole

Generic Formulation: AripiprazoleSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 204
30-Day Fills 344.5
Days Supply 10,323
VA State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills55.7
Peer Average Days Supply1,622
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 397.6% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $20,055.02 across this reporting matrix range.

Provider Avg Cost Per Claim

$98.31

State Avg Cost Per Claim

$130.93

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A piperazine and quinolone derivative that is used primarily as an antipsychotic agent. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as an adjunct therapy for the treatment of depression.

Therapeutic Applications

Aripiprazole is used to treat certain mental/mood disorders (such as bipolar disorder, schizophrenia, Tourette's syndrome, and irritability associated with autistic disorder). It may also be used in combination with other medication to treat depression. Aripiprazole is known as an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural chemicals in the brain (neurotransmitters). This medication can decrease hallucinations and improve your concentration. It helps you to think more clearly and positively about yourself, feel less nervous, and take a more active part in everyday life. Aripiprazole can treat severe mood swings and decrease how often mood swings occur.

Aristada

Generic Formulation: Aripiprazole LauroxilSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 92
30-Day Fills 95.5
Days Supply 2,692
VA State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills24.5
Peer Average Days Supply707
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 338.1% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $258,617.44 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,811.06

State Avg Cost Per Claim

$2,948.19

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Extended-release aripiprazole injection is used to treat a mental/mood disorder called schizophrenia. This medication can decrease hallucinations (hearing/seeing things that are not there) and improve your concentration. It also helps you to think more clearly, feel less nervous, and take a more active part in everyday life. Some brands of this medication are also used to treat bipolar disorder. It can help to decrease extreme changes in mood and help you feel less agitated. Extended-release aripiprazole injection is a long-acting psychiatric medication known as an atypical antipsychotic. It works by helping to restore the balance of certain natural substances in the brain.

Atomoxetine Hcl

Generic Formulation: Atomoxetine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 13
30-Day Fills 23.0
Days Supply 690
VA State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills22.5
Peer Average Days Supply649
Conservative Utilization

This provider writes prescriptions for this formulation 31.6% less frequently than the standard regional baseline metric for practitioners inside VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,859.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$143.02

State Avg Cost Per Claim

$148.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A propylamine derivative and selective ADRENERGIC UPTAKE INHIBITOR that is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.

Therapeutic Applications

Atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD) as part of a total treatment plan, including psychological, social, and other treatments. It may help to increase the ability to pay attention, concentrate, stay focused, and stop fidgeting. It is thought to work by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Austedo

Generic Formulation: DeutetrabenazineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 95
30-Day Fills 95.0
Days Supply 2,850
VA State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills23.8
Peer Average Days Supply622
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 313.0% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $605,804.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$6,376.89

State Avg Cost Per Claim

$6,221.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Deutetrabenazine is used to decrease involuntary movements (chorea) caused by Huntington's disease. It is also used to treat involuntary movements of the face, tongue, or other body parts (tardive dyskinesia). However, it is not a cure for the Huntington's disease or tardive dyskinesia. Reducing involuntary movements will help you take part in more of your normal daily activities. This medication is thought to work by decreasing the amount of certain natural substances in the brain that affect how your nerves and muscles work (monoamines such as dopamine, serotonin, and norepinephrine).

Benztropine Mesylate

Generic Formulation: Benztropine MesylateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 443
30-Day Fills 840.6
Days Supply 25,108
VA State Average Benchmarks
Peer Average Claims54.0
Peer Average 30-Day Fills63.7
Peer Average Days Supply1,834
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 720.4% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,404.60 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.97

State Avg Cost Per Claim

$13.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.

Therapeutic Applications

Benztropine is used to treat symptoms of Parkinson's disease or involuntary movements due to the side effects of certain psychiatric drugs (antipsychotics such as chlorpromazine/haloperidol). Benztropine belongs to a class of medication called anticholinergics that work by blocking a certain natural substance (acetylcholine). This helps decrease muscle stiffness, sweating, and the production of saliva, and helps improve walking ability in people with Parkinson's disease. Anticholinergics can stop severe muscle spasms of the back, neck, and eyes that are sometimes caused by psychiatric drugs. It can also decrease other side effects such as muscle stiffness/rigidity (extrapyramidal signs-EPS). It is not helpful in treating movement problems caused by tardive dyskinesia and may worsen them. Benztropine should not be used by children younger than 3 years.

Bupropion Hcl

Generic Formulation: Bupropion HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 15
30-Day Fills 29.0
Days Supply 861
VA State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills27.3
Peer Average Days Supply799
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $517.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$34.49

State Avg Cost Per Claim

$29.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Bupropion is used to treat depression. It can improve your mood and feelings of well-being. It may work by helping to restore the balance of certain natural chemicals (neurotransmitters) in your brain.

Bupropion Hcl Sr

Generic Formulation: Bupropion HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 52
30-Day Fills 104.0
Days Supply 3,077
VA State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills44.9
Peer Average Days Supply1,329
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 108.0% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,671.27 across this reporting matrix range.

Provider Avg Cost Per Claim

$32.14

State Avg Cost Per Claim

$31.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Bupropion is used to treat depression. It can improve your mood and feelings of well-being. It may work by helping to restore the balance of certain natural chemicals (neurotransmitters) in your brain.

Bupropion Xl

Generic Formulation: Bupropion HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 240
30-Day Fills 492.4
Days Supply 14,742
VA State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills68.5
Peer Average Days Supply2,039
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 585.7% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,718.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$32.16

State Avg Cost Per Claim

$40.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Bupropion is used to treat depression. It can improve your mood and feelings of well-being. It may work by helping to restore the balance of certain natural chemicals (neurotransmitters) in your brain.

Buspirone Hcl

Generic Formulation: Buspirone HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 248
30-Day Fills 438.6
Days Supply 13,097
VA State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills65.9
Peer Average Days Supply1,921
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 476.7% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,125.46 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.63

State Avg Cost Per Claim

$19.47

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat anxiety. It may help you think more clearly, relax, worry less, and take part in everyday life. It may also help you to feel less jittery and irritable, and may control symptoms such as trouble sleeping, sweating, and pounding heartbeat. Buspirone is a medication for anxiety (anxiolytic) that works by affecting certain natural substances in the brain (neurotransmitters).

Caplyta

Generic Formulation: Lumateperone TosylateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 72
30-Day Fills 76.0
Days Supply 2,264
VA State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills24.4
Peer Average Days Supply716
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 200.0% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $127,391.55 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,769.33

State Avg Cost Per Claim

$1,580.53

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Lumateperone is used to treat certain mental/mood disorders (such as schizophrenia, episodes of depression associated with bipolar disorder). This medication helps you to think more clearly, feel less nervous, and take part in everyday life. It may help to decrease hallucinations (hearing/seeing things that are not there). It may also improve your mood, sleep, appetite, and energy level. Lumateperone belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.

Citalopram Hbr

Generic Formulation: Citalopram HydrobromideSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 130
30-Day Fills 248.2
Days Supply 7,427
VA State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills77.5
Peer Average Days Supply2,301
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 251.4% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,229.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.46

State Avg Cost Per Claim

$8.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A furancarbonitrile that is one of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.

Therapeutic Applications

Citalopram is used to treat depression. It may improve your energy level and feelings of well-being. Citalopram is known as a selective serotonin reuptake inhibitor (SSRI). This medication works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

Clonazepam

Generic Formulation: ClonazepamSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 391
30-Day Fills 409.6
Days Supply 12,006
VA State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills52.3
Peer Average Days Supply1,476
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 750.0% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,331.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.96

State Avg Cost Per Claim

$8.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.

Therapeutic Applications

Clonazepam is used to prevent and control seizures. This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines.

Clonidine Hcl

Generic Formulation: Clonidine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 43
30-Day Fills 65.2
Days Supply 1,951
VA State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills53.8
Peer Average Days Supply1,582
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 59.3% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $189.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.40

State Avg Cost Per Claim

$9.97

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used alone or with other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Clonidine belongs to a class of drugs (central alpha agonists) that act in the brain to lower blood pressure. It works by relaxing blood vessels so blood can flow more easily.

Clozapine

Generic Formulation: ClozapineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 238
30-Day Fills 242.1
Days Supply 7,017
VA State Average Benchmarks
Peer Average Claims60.0
Peer Average 30-Day Fills60.9
Peer Average Days Supply1,375
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 296.7% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $22,552.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$94.76

State Avg Cost Per Claim

$80.69

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.

Therapeutic Applications

See also Warning section. This medication is used to treat certain mental/mood disorders (schizophrenia, schizoaffective disorders). Clozapine is a psychiatric medication (anti-psychotic type) that works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain. Clozapine decreases hallucinations and helps prevent suicide in people who are likely to try to harm themselves. It helps you to think more clearly and positively about yourself, feel less nervous, and take part in everyday life.

Desvenlafaxine Succinate Er

Generic Formulation: Desvenlafaxine SuccinateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 14
30-Day Fills 26.0
Days Supply 780
VA State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills33.0
Peer Average Days Supply977
Conservative Utilization

This provider writes prescriptions for this formulation 36.4% less frequently than the standard regional baseline metric for practitioners inside VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $704.57 across this reporting matrix range.

Provider Avg Cost Per Claim

$50.33

State Avg Cost Per Claim

$109.41

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexanol and phenol derivative and metabolite of venlafaxine that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.

Therapeutic Applications

Desvenlafaxine is used to treat depression. It may improve your mood, feelings of well-being, and energy level. Desvenlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Dextroamphetamine-Amphetamine

Generic Formulation: Dextroamphetamine/AmphetamineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 25
30-Day Fills 26.0
Days Supply 780
VA State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills31.6
Peer Average Days Supply931
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $895.48 across this reporting matrix range.

Provider Avg Cost Per Claim

$35.82

State Avg Cost Per Claim

$42.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to treat attention deficit hyperactivity disorder - ADHD. It works by changing the amounts of certain natural substances in the brain. Amphetamine/dextroamphetamine belongs to a class of drugs known as stimulants. It can help increase your ability to pay attention, stay focused on an activity, and control behavior problems. It may also help you to organize your tasks and improve listening skills. This drug is also used to treat a certain sleeping disorder (narcolepsy) to help you stay awake during the day. It should not be used to treat tiredness or to hold off sleep in people who do not have a sleep disorder.

Divalproex Sodium

Generic Formulation: Divalproex SodiumSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 108
30-Day Fills 218.2
Days Supply 6,514
VA State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills50.7
Peer Average Days Supply1,435
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 157.1% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,173.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$29.38

State Avg Cost Per Claim

$49.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.

Therapeutic Applications

This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Divalproex Sodium Er

Generic Formulation: Divalproex SodiumSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 114
30-Day Fills 172.5
Days Supply 5,157
VA State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills45.3
Peer Average Days Supply1,304
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 225.7% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,252.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$54.84

State Avg Cost Per Claim

$96.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.

Therapeutic Applications

This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Donepezil Hcl

Generic Formulation: Donepezil HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 34
30-Day Fills 62.0
Days Supply 1,848
VA State Average Benchmarks
Peer Average Claims50.0
Peer Average 30-Day Fills87.0
Peer Average Days Supply2,547
Conservative Utilization

This provider writes prescriptions for this formulation 32.0% less frequently than the standard regional baseline metric for practitioners inside VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $431.43 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.69

State Avg Cost Per Claim

$18.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain.

Doxepin Hcl

Generic Formulation: Doxepin HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 30
30-Day Fills 47.0
Days Supply 1,410
VA State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills31.8
Peer Average Days Supply935
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 36.4% more claims than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $954.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$31.83

State Avg Cost Per Claim

$42.43

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat mental/mood problems such as depression and anxiety. It may help improve mood and feelings of well-being, relieve anxiety and tension, help you sleep better, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters) in the brain.

Duloxetine Hcl

Generic Formulation: Duloxetine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 115
30-Day Fills 238.0
Days Supply 7,021
VA State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills89.6
Peer Average Days Supply2,656
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 144.7% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,628.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.86

State Avg Cost Per Claim

$43.90

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.

Therapeutic Applications

Duloxetine is used to treat depression and anxiety. In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Escitalopram Oxalate

Generic Formulation: Escitalopram OxalateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 204
30-Day Fills 348.2
Days Supply 10,390
VA State Average Benchmarks
Peer Average Claims48.0
Peer Average 30-Day Fills94.0
Peer Average Days Supply2,781
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 325.0% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,001.60 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.81

State Avg Cost Per Claim

$16.41

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder.

Therapeutic Applications

Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI). It may improve your energy level and feelings of well-being and decrease nervousness.

Fanapt

Generic Formulation: IloperidoneSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 20
30-Day Fills 21.0
Days Supply 631
VA State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills17.3
Peer Average Days Supply488
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $31,277.83 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,563.89

State Avg Cost Per Claim

$2,357.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain mental/mood disorders (such as schizophrenia). Iloperidone helps you to think more clearly, feel less nervous, and take part in everyday life. It may also help to decrease hallucinations (hearing/seeing things that are not there). Iloperidone is a psychiatric medication that belongs to the class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.

Fluoxetine Hcl

Generic Formulation: Fluoxetine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 449
30-Day Fills 754.8
Days Supply 22,580
VA State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills70.8
Peer Average Days Supply2,101
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 1,147.2% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,932.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.76

State Avg Cost Per Claim

$14.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.

Therapeutic Applications

This long-acting form of fluoxetine is used to treat depression in people who have been successfully treated with the form of fluoxetine that is taken daily. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI). SSRIs work by helping to restore the balance of certain natural substances in the brain (neurotransmitters such as serotonin). Fluoxetine may decrease anxiety, improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living.

Fluphenazine Decanoate

Generic Formulation: Fluphenazine DecanoateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 14
30-Day Fills 15.6
Days Supply 456
VA State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills23.8
Peer Average Days Supply625
Conservative Utilization

This provider writes prescriptions for this formulation 33.3% less frequently than the standard regional baseline metric for practitioners inside VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,292.48 across this reporting matrix range.

Provider Avg Cost Per Claim

$235.18

State Avg Cost Per Claim

$114.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is a long-acting form of fluphenazine that is used to treat certain mental/mood problems (chronic schizophrenia). Fluphenazine decanoate is usually used in patients who have benefited from regular doses of short-acting forms of fluphenazine and who may benefit from long-term (maintenance) treatment with less frequent dosing. Fluphenazine belongs to a class of medications called phenothiazines and is also referred to as a neuroleptic. It works by affecting the balance of natural chemicals (neurotransmitters) in the brain. Some of the benefits of continued use of this medication include reduced episodes of hallucinations, delusions, or bizarre behaviors that occur in patients with schizophrenia. This product does not work right away. It may take 1-3 days to notice an effect from this drug, and up to 4 days to experience the full effect. For severe agitation or other symptoms, use a short-acting medication as directed by your doctor. This medication is not recommended for use in children under 12 years of age. Also, it should not be used to manage behavioral problems in patients with mental retardation.

Fluphenazine Hcl

Generic Formulation: Fluphenazine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 29
30-Day Fills 60.0
Days Supply 1,770
VA State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills27.7
Peer Average Days Supply767
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,838.57 across this reporting matrix range.

Provider Avg Cost Per Claim

$373.74

State Avg Cost Per Claim

$299.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE.

Therapeutic Applications

This medication is used to treat symptoms of a certain type of mental/mood condition (schizophrenia). Fluphenazine belongs to a class of medications called phenothiazines and is also referred to as a neuroleptic. It works by affecting the balance of natural chemicals (neurotransmitters) in the brain. Some of the benefits of continued use of this medication include reduced episodes of hallucinations, delusions, or bizarre behaviors that occur in patients with schizophrenia. This medication is not recommended for use in children under 12 years of age. Also, it should not be used to manage behavioral problems in patients with mental retardation.

Fluvoxamine Maleate

Generic Formulation: Fluvoxamine MaleateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 22
30-Day Fills 22.0
Days Supply 660
VA State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills28.2
Peer Average Days Supply796
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $381.60 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.35

State Avg Cost Per Claim

$48.01

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS.

Therapeutic Applications

Fluvoxamine is used to treat obsessive-compulsive disorder (OCD). It helps decrease thoughts that are unwanted or that don't go away (obsessions), and it helps to reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, checking) that interfere with daily living. Fluvoxamine is known as a selective serotonin reuptake inhibitor (SSRI). This medication works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

Gabapentin

Generic Formulation: GabapentinSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 166
30-Day Fills 250.3
Days Supply 7,458
VA State Average Benchmarks
Peer Average Claims89.0
Peer Average 30-Day Fills132.3
Peer Average Days Supply3,808
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 86.5% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,335.02 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.07

State Avg Cost Per Claim

$19.87

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Haloperidol

Generic Formulation: HaloperidolSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 182
30-Day Fills 305.5
Days Supply 9,086
VA State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills41.3
Peer Average Days Supply1,148
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 391.9% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,339.82 across this reporting matrix range.

Provider Avg Cost Per Claim

$34.83

State Avg Cost Per Claim

$38.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)

Therapeutic Applications

Haloperidol is used to treat certain mental/mood disorders (such as schizophrenia, schizoaffective disorders). This medicine helps you to think more clearly, feel less nervous, and take part in everyday life. It can also help prevent suicide in people who are likely to harm themselves. It also reduces aggression and the desire to hurt others. It can decrease negative thoughts and hallucinations. Haloperidol can also be used to treat uncontrolled movements and outbursts of words/sounds related to Tourette's syndrome. Haloperidol is also used for severe behavior problems in hyperactive children when other treatments or medications have not worked. Haloperidol is a psychiatric medication (antipsychotic-type) that works by helping to restore the balance of certain natural substances in the brain (neurotransmitters).

Haloperidol Decanoate

Generic Formulation: Haloperidol DecanoateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 252
30-Day Fills 252.0
Days Supply 6,874
VA State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills36.5
Peer Average Days Supply950
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 620.0% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $12,205.19 across this reporting matrix range.

Provider Avg Cost Per Claim

$48.43

State Avg Cost Per Claim

$63.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Haloperidol decanoate is used for long-term treatment of a certain mental/mood disorder (schizophrenia). It may be used in people who have trouble remembering to take medication every day. This medicine helps you to think more clearly, feel less nervous, and take part in everyday life. It can also prevent suicide in people who are likely to harm themselves. It also reduces aggression and the desire to hurt others. It can decrease negative thoughts and hallucinations. Haloperidol decanoate is a long-acting form of psychiatric medication (antipsychotic-type) that works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain.

Hydroxyzine Hcl

Generic Formulation: Hydroxyzine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 46
30-Day Fills 78.0
Days Supply 2,340
VA State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills37.6
Peer Average Days Supply985
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 58.6% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $975.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.21

State Avg Cost Per Claim

$18.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Hydroxyzine is used to treat itching caused by allergies. It is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Hydroxyzine may also be used short-term to treat anxiety or to help you feel sleepy/relaxed before and after surgery.

Hydroxyzine Pamoate

Generic Formulation: Hydroxyzine PamoateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 120
30-Day Fills 215.0
Days Supply 6,450
VA State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills39.6
Peer Average Days Supply1,058
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 263.6% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,730.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.42

State Avg Cost Per Claim

$12.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.

Therapeutic Applications

Hydroxyzine is used to treat itching caused by allergies. It is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Hydroxyzine may also be used short-term to treat anxiety or to help you feel sleepy/relaxed before and after surgery.

Ingrezza

Generic Formulation: Valbenazine TosylateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 44
30-Day Fills 44.0
Days Supply 1,316
VA State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills18.8
Peer Average Days Supply541
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 144.4% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $341,723.33 across this reporting matrix range.

Provider Avg Cost Per Claim

$7,766.44

State Avg Cost Per Claim

$7,671.34

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Valbenazine is used to treat involuntary movements of the face, tongue, or other body parts (tardive dyskinesia). This medication is thought to work by decreasing the amount of certain natural substances in the brain that affect how your nerves and muscles work (monoamines such as dopamine, serotonin, and norepinephrine).

Invega Sustenna

Generic Formulation: Paliperidone PalmitateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 268
30-Day Fills 268.0
Days Supply 7,406
VA State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills42.2
Peer Average Days Supply1,170
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 538.1% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $735,203.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,743.30

State Avg Cost Per Claim

$2,746.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.

Therapeutic Applications

Paliperidone is used to treat a certain mental/mood disorder called schizophrenia. This medication can decrease hallucinations, help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Paliperidone is an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain. This long-acting form of paliperidone is used only after you have received treatment with either the monthly injectable form of this drug for at least 4 months, or the every-3-month injectable form for at least 3 months.

Invega Trinza

Generic Formulation: Paliperidone PalmitateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 28
30-Day Fills 82.2
Days Supply 2,466
VA State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills57.0
Peer Average Days Supply1,705
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 47.4% more claims than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $229,439.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$8,194.25

State Avg Cost Per Claim

$8,295.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.

Therapeutic Applications

Paliperidone is used to treat a certain mental/mood disorder called schizophrenia. This medication can decrease hallucinations, help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Paliperidone is an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain. This long-acting form of paliperidone is used only after you have received treatment with either the monthly injectable form of this drug for at least 4 months, or the every-3-month injectable form for at least 3 months.

Lamotrigine

Generic Formulation: LamotrigineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 562
30-Day Fills 1,046.3
Days Supply 31,085
VA State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills64.3
Peer Average Days Supply1,890
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 1,305.0% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,603.93 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.75

State Avg Cost Per Claim

$17.31

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER.

Therapeutic Applications

Lamotrigine is used alone or with other medications to prevent and control seizures. It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections).

Latuda

Generic Formulation: Lurasidone HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 34
30-Day Fills 38.0
Days Supply 1,140
VA State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills29.7
Peer Average Days Supply830
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $64,930.73 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,909.73

State Avg Cost Per Claim

$1,652.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic α2A and α2C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER.

Therapeutic Applications

This medication is used to treat certain mental/mood disorders (such as schizophrenia, depression associated with bipolar disorder). Lurasidone helps you to think more clearly, feel less nervous, and take part in everyday life. It may also help to decrease hallucinations (hearing/seeing things that are not there). In addition, this medication may improve your mood, sleep, appetite, and energy level. Lurasidone is a psychiatric medication that belongs to the class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.

Linzess

Generic Formulation: LinaclotideSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 330
VA State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills43.1
Peer Average Days Supply1,276
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.7% less volume than the regional standard for practitioners inside VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,191.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$562.87

State Avg Cost Per Claim

$785.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

See also Warning section. Linaclotide is used to treat certain types of bowel problems (irritable bowel syndrome with constipation, chronic idiopathic constipation). It works by increasing fluid in your intestines and helping speed up movement of food through the gut. Linaclotide may improve stool texture and lessen symptoms such as bloating, abdominal pain/discomfort, straining, and feelings of incomplete bowel movements.

Lithium Carbonate

Generic Formulation: Lithium CarbonateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 53
30-Day Fills 95.0
Days Supply 2,777
VA State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills36.1
Peer Average Days Supply1,034
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 89.3% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $557.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.52

State Avg Cost Per Claim

$9.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems.

Therapeutic Applications

This medication is used to treat manic-depressive disorder (bipolar disorder). It works to stabilize the mood and reduce extremes in behavior by restoring the balance of certain natural substances (neurotransmitters) in the brain. Some of the benefits of continued use of this medication include decreasing how often manic episodes occur and decreasing the symptoms of manic episodes, such as exaggerated feelings of well-being, feelings that others wish to harm you, irritability, anxiousness, rapid/loud speech, and aggressive/hostile behaviors.

Lithium Carbonate Er

Generic Formulation: Lithium CarbonateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 54
30-Day Fills 87.2
Days Supply 2,587
VA State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills29.9
Peer Average Days Supply871
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 145.5% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,427.82 across this reporting matrix range.

Provider Avg Cost Per Claim

$26.44

State Avg Cost Per Claim

$17.97

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems.

Therapeutic Applications

This medication is used to treat manic-depressive disorder (bipolar disorder). It works to stabilize the mood and reduce extremes in behavior by restoring the balance of certain natural substances (neurotransmitters) in the brain. Some of the benefits of continued use of this medication include decreasing how often manic episodes occur and decreasing the symptoms of manic episodes, such as exaggerated feelings of well-being, feelings that others wish to harm you, irritability, anxiousness, rapid/loud speech, and aggressive/hostile behaviors.

Lorazepam

Generic Formulation: LorazepamSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 88
30-Day Fills 88.0
Days Supply 2,330
VA State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills49.2
Peer Average Days Supply1,260
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 95.6% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $377.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.29

State Avg Cost Per Claim

$7.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Therapeutic Applications

This medication is used to treat serious seizures that do not stop (status epilepticus). It is also used before surgeries or procedures to cause drowsiness, decrease anxiety, and cause forgetfulness about the procedure or surgery. Lorazepam belongs to a class of medications called benzodiazepines, which produce a calming effect on the brain and nerves (central nervous system). It is thought to work by increasing the effect of a certain natural chemical (GABA) in the brain.

Lurasidone Hcl

Generic Formulation: Lurasidone HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 105
30-Day Fills 157.2
Days Supply 4,706
VA State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$310.87

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Memantine Hcl

Generic Formulation: Memantine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 22
30-Day Fills 42.0
Days Supply 1,260
VA State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills70.4
Peer Average Days Supply2,029
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 53.2% less volume than the regional standard for practitioners inside VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,661.20 across this reporting matrix range.

Provider Avg Cost Per Claim

$120.96

State Avg Cost Per Claim

$53.96

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.

Methylphenidate Hcl

Generic Formulation: Methylphenidate HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 33
30-Day Fills 33.0
Days Supply 990
VA State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills20.6
Peer Average Days Supply586
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 73.7% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $807.02 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.46

State Avg Cost Per Claim

$34.87

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat attention deficit hyperactivity disorder - ADHD. It works by changing the amounts of certain natural substances in the brain. Methylphenidate belongs to a class of drugs known as stimulants. It can help increase your ability to pay attention, stay focused on an activity, and control behavior problems. It may also help you to organize your tasks and improve listening skills.

Mirtazapine

Generic Formulation: MirtazapineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 90
30-Day Fills 163.8
Days Supply 4,915
VA State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills62.3
Peer Average Days Supply1,810
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 119.5% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,193.92 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.38

State Avg Cost Per Claim

$24.49

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Therapeutic Applications

Mirtazapine is used to treat depression. It improves mood and feelings of well-being. Mirtazapine is an antidepressant that works by restoring the balance of natural chemicals (neurotransmitters) in the brain.

Naltrexone Hcl

Generic Formulation: Naltrexone HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 36
30-Day Fills 44.0
Days Supply 1,292
VA State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills27.1
Peer Average Days Supply779
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 63.6% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,389.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$38.60

State Avg Cost Per Claim

$66.80

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to prevent people who have been addicted to certain drugs (opiates) from taking them again. It is used as part of a complete treatment program for drug abuse (such as compliance monitoring, counseling, behavioral contract, lifestyle changes). This medication must not be used in people currently taking opiates, including methadone. Doing so can cause sudden withdrawal symptoms. Naltrexone belongs to a class of drugs known as opiate antagonists. It works in the brain to prevent opiate effects (such as feelings of well-being, pain relief). It also decreases the desire to take opiates. Ask your doctor or pharmacist if you should have naloxone available to treat opioid overdose. Teach your family or household members about the signs of an opioid overdose and how to treat it. This medication is also used to treat alcohol abuse. It can help people drink less alcohol or stop drinking altogether. It also decreases the desire to drink alcohol when used with a treatment program that includes counseling, support, and lifestyle changes.

Nortriptyline Hcl

Generic Formulation: Nortriptyline HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 11
30-Day Fills 21.0
Days Supply 628
VA State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills39.9
Peer Average Days Supply1,188
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $201.05 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.28

State Avg Cost Per Claim

$18.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat mental/mood problems such as depression. It may help improve mood and feelings of well-being, relieve anxiety and tension, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters) in the brain.

Olanzapine

Generic Formulation: OlanzapineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 146
30-Day Fills 250.2
Days Supply 7,475
VA State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills52.5
Peer Average Days Supply1,484
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 231.8% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,487.52 across this reporting matrix range.

Provider Avg Cost Per Claim

$30.74

State Avg Cost Per Claim

$38.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy.

Therapeutic Applications

Olanzapine is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder). It may also be used in combination with other medication to treat depression. This medication can help to decrease hallucinations and help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Olanzapine belongs to a class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. Talk to the doctor about the risks and benefits of treatment (especially when used by teenagers). See also Precautions section.

Oxcarbazepine

Generic Formulation: OxcarbazepineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 120
30-Day Fills 198.2
Days Supply 5,929
VA State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills39.7
Peer Average Days Supply1,152
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 328.6% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,417.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$45.15

State Avg Cost Per Claim

$68.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A carbamazepine derivative that acts as a voltage-gated sodium channel blocker. It is used for the treatment of PARTIAL SEIZURES with or without secondary generalization. It is also an inducer of CYTOCHROME P-450 CYP3A4.

Therapeutic Applications

Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy).

Paliperidone Er

Generic Formulation: PaliperidoneSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 31
30-Day Fills 35.0
Days Supply 1,050
VA State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills28.5
Peer Average Days Supply795
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,818.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$348.97

State Avg Cost Per Claim

$449.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.

Therapeutic Applications

This medication is used to treat certain mental/mood disorders (such as schizophrenia, schizoaffective disorder). This medication can decrease hallucinations and help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Paliperidone belongs to a class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.

Paroxetine Hcl

Generic Formulation: Paroxetine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 36
30-Day Fills 68.0
Days Supply 2,040
VA State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills51.9
Peer Average Days Supply1,540
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 38.5% more claims than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $416.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.57

State Avg Cost Per Claim

$15.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Paroxetine is used to treat depression, panic attacks, anxiety disorders, and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Paroxetine is known as a selective serotonin reuptake inhibitor (SSRI). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. Paroxetine may lessen premenstrual symptoms such as irritability, increased appetite, and depression.

Perphenazine

Generic Formulation: PerphenazineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 124
30-Day Fills 206.2
Days Supply 6,163
VA State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills24.1
Peer Average Days Supply696
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 520.0% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,692.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$70.10

State Avg Cost Per Claim

$78.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE.

Therapeutic Applications

This medication is used to treat certain mental/mood disorders (such as schizophrenia, manic phase of bipolar disorder, schizoaffective disorder). This medicine helps you to think more clearly, feel less nervous, and take part in everyday life. It can reduce aggressive behavior and the desire to hurt yourself/others. It may also help to decrease hallucinations (such as hearing/seeing things that are not there). Perphenazine is a psychiatric medication (antipsychotic-type) that works by helping to restore the balance of certain natural substances (such as dopamine) in the brain.

Prazosin Hcl

Generic Formulation: Prazosin HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 92
30-Day Fills 158.0
Days Supply 4,706
VA State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills38.6
Peer Average Days Supply1,124
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 228.6% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,523.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$27.43

State Avg Cost Per Claim

$32.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.

Therapeutic Applications

Prazosin is used with or without other medications to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Prazosin belongs to a class of medications called alpha blockers. It works by relaxing and widening blood vessels so blood can flow more easily.

Propranolol Hcl

Generic Formulation: Propranolol HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 45
30-Day Fills 93.0
Days Supply 2,784
VA State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills42.1
Peer Average Days Supply1,237
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 95.7% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,172.73 across this reporting matrix range.

Provider Avg Cost Per Claim

$26.06

State Avg Cost Per Claim

$26.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This formulation of propranolol is used for infants and children to treat a certain benign tumor (proliferating infantile hemangioma). It helps to shrink the tumor. Propranolol belongs to a class of drugs known as beta blockers.

Quetiapine Fumarate

Generic Formulation: Quetiapine FumarateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 382
30-Day Fills 631.3
Days Supply 18,857
VA State Average Benchmarks
Peer Average Claims53.0
Peer Average 30-Day Fills73.2
Peer Average Days Supply2,103
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 620.8% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,545.44 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.75

State Avg Cost Per Claim

$30.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER.

Therapeutic Applications

This medication is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder, sudden episodes of mania or depression associated with bipolar disorder). Quetiapine is known as an anti-psychotic drug (atypical type). It works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain. This medication can decrease hallucinations and improve your concentration. It helps you to think more clearly and positively about yourself, feel less nervous, and take a more active part in everyday life. It may also improve your mood, sleep, appetite, and energy level. Quetiapine can help prevent severe mood swings or decrease how often mood swings occur.

Quetiapine Fumarate Er

Generic Formulation: Quetiapine FumarateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 48
30-Day Fills 92.0
Days Supply 2,760
VA State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills25.6
Peer Average Days Supply734
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 128.6% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,908.45 across this reporting matrix range.

Provider Avg Cost Per Claim

$185.59

State Avg Cost Per Claim

$135.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER.

Therapeutic Applications

This medication is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder, sudden episodes of mania or depression associated with bipolar disorder). Quetiapine is known as an anti-psychotic drug (atypical type). It works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain. This medication can decrease hallucinations and improve your concentration. It helps you to think more clearly and positively about yourself, feel less nervous, and take a more active part in everyday life. It may also improve your mood, sleep, appetite, and energy level. Quetiapine can help prevent severe mood swings or decrease how often mood swings occur.

Rexulti

Generic Formulation: BrexpiprazoleSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 14
30-Day Fills 16.0
Days Supply 480
VA State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills21.8
Peer Average Days Supply632
Conservative Utilization

This provider writes prescriptions for this formulation 30.0% less frequently than the standard regional baseline metric for practitioners inside VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $23,343.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,667.38

State Avg Cost Per Claim

$1,496.08

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain mental/mood disorders (such as schizophrenia, depression). Brexpiprazole helps you to think more clearly, feel less nervous, and take part in everyday life. It may also help to decrease hallucinations (hearing/seeing things that are not there). In addition, this medication may improve your mood, sleep, appetite, and energy level. Brexpiprazole is a psychiatric medication that belongs to the class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.

Risperidone

Generic Formulation: RisperidoneSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 156
30-Day Fills 262.6
Days Supply 7,845
VA State Average Benchmarks
Peer Average Claims48.0
Peer Average 30-Day Fills57.8
Peer Average Days Supply1,653
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 225.0% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,108.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.93

State Avg Cost Per Claim

$15.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.

Therapeutic Applications

Risperidone is used to treat a certain mental/mood disorder called schizophrenia. This medication can decrease hallucinations, help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Risperidone is an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural substances in the brain.

Sertraline Hcl

Generic Formulation: Sertraline HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 222
30-Day Fills 404.6
Days Supply 12,067
VA State Average Benchmarks
Peer Average Claims56.0
Peer Average 30-Day Fills108.0
Peer Average Days Supply3,191
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 296.4% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,760.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.93

State Avg Cost Per Claim

$11.85

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Sertraline is used to treat depression, panic attacks, obsessive compulsive disorder, post-traumatic stress disorder, social anxiety disorder (social phobia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. It may also reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, and checking) that interfere with daily living. Sertraline is known as a selective serotonin reuptake inhibitor (SSRI). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

Temazepam

Generic Formulation: TemazepamSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 29
30-Day Fills 29.2
Days Supply 697
VA State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills26.6
Peer Average Days Supply784
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 26.1% more claims than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $190.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.56

State Avg Cost Per Claim

$12.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.

Therapeutic Applications

This medication is used to treat a certain sleep problem (insomnia). It may help you fall asleep faster, stay asleep longer, and lessen how often you wake up during the night, so you can get a better night's rest. Temazepam belongs to a class of drugs called benzodiazepines. It acts on your brain to produce a calming effect. Use of this medication is usually limited to short treatment periods of 1 to 2 weeks or less. If your insomnia continues for a longer time, talk to your doctor to see if you need other treatment.

Topiramate

Generic Formulation: TopiramateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 46
30-Day Fills 65.2
Days Supply 1,917
VA State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills55.5
Peer Average Days Supply1,643
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 48.4% more claims than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $658.59 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.32

State Avg Cost Per Claim

$20.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss.

Therapeutic Applications

Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). This medication is also used to prevent migraine headaches and decrease how often you get them. Topiramate will not treat a migraine headache once it occurs. If you get a migraine headache, treat it as directed by your doctor (such as by taking pain medication, lying down in a dark room). Topiramate is known as an anticonvulsant or antiepileptic drug.

Trazodone Hcl

Generic Formulation: Trazodone HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 432
30-Day Fills 876.0
Days Supply 26,256
VA State Average Benchmarks
Peer Average Claims60.0
Peer Average 30-Day Fills105.3
Peer Average Days Supply3,101
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 620.0% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,115.20 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.16

State Avg Cost Per Claim

$12.68

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat depression. It may help to improve your mood, appetite, and energy level as well as decrease anxiety and insomnia related to depression. Trazodone works by helping to restore the balance of a certain natural chemical (serotonin) in the brain.

Trihexyphenidyl Hcl

Generic Formulation: Trihexyphenidyl HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 16
30-Day Fills 46.0
Days Supply 1,355
VA State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills23.6
Peer Average Days Supply677
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $256.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.01

State Avg Cost Per Claim

$15.78

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Trihexyphenidyl is used to treat symptoms of Parkinson's disease or involuntary movements due to the side effects of certain psychiatric drugs (antipsychotics such as chlorpromazine/haloperidol). Trihexyphenidyl belongs to a class of medication called anticholinergics that work by blocking a certain natural substance (acetylcholine). This helps decrease muscle stiffness, sweating, and the production of saliva, and helps improve walking ability in people with Parkinson's disease. Anticholinergics can stop severe muscle spasms of the back, neck, and eyes that are sometimes caused by psychiatric drugs. It can also decrease other side effects such as muscle stiffness/rigidity (extrapyramidal signs-EPS). It is not helpful in treating movement problems caused by tardive dyskinesia and may worsen them.

Trintellix

Generic Formulation: Vortioxetine HydrobromideSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 185
30-Day Fills 271.0
Days Supply 8,105
VA State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills26.2
Peer Average Days Supply747
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 825.0% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $135,104.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$730.30

State Avg Cost Per Claim

$594.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A piperazine derivative that acts as a serotonin reuptake inhibitor, as a 5-HT3 receptor antagonist, and 5-HT1A receptor agonist. It is used for the treatment of anxiety and depression.

Therapeutic Applications

This medication is used to treat depression. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Vortioxetine is an SSRI (selective serotonin reuptake inhibitor) and serotonin receptor modulator. This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living.

Venlafaxine Hcl Er

Generic Formulation: Venlafaxine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 149
30-Day Fills 347.9
Days Supply 10,422
VA State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills61.2
Peer Average Days Supply1,814
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 380.6% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,014.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$26.94

State Avg Cost Per Claim

$32.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Venlafaxine is used to treat depression, anxiety, panic attacks, and social anxiety disorder (social phobia). It may improve your mood and energy level and may help restore your interest in daily living. It may also decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. Venlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Vilazodone Hcl

Generic Formulation: Vilazodone HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 14
30-Day Fills 27.8
Days Supply 810
VA State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills23.0
Peer Average Days Supply671
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,353.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$96.65

State Avg Cost Per Claim

$185.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzofuran, indole, and piperazine derivative that functions as a SEROTONIN UPTAKE INHIBITOR and partial SEROTONIN 5-HT1 RECEPTOR AGONIST. It is used as an ANTIDEPRESSIVE AGENT.

Therapeutic Applications

Vilazodone is used to treat depression. It is an SSRI (selective serotonin reuptake inhibitor) and partial serotonin receptor agonist. It works by helping to restore the balance of certain natural substances in the brain (neurotransmitters such as serotonin). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living.

Vraylar

Generic Formulation: Cariprazine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 73
30-Day Fills 101.0
Days Supply 3,030
VA State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills25.4
Peer Average Days Supply734
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 204.2% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $146,654.20 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,008.96

State Avg Cost Per Claim

$1,428.25

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Cariprazine is used to treat certain mental/mood disorders (such as bipolar disorder, bipolar depression, schizophrenia). Cariprazine belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. This medication can decrease hallucinations, help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life.

Ziprasidone Hcl

Generic Formulation: Ziprasidone HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 51
30-Day Fills 123.0
Days Supply 3,690
VA State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills35.1
Peer Average Days Supply1,019
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 82.1% higher than the standard regional baseline profile for VA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,201.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$102.00

State Avg Cost Per Claim

$96.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain mental/mood disorders (schizophrenia, bipolar disorder). This medication can decrease hallucinations and help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Ziprasidone belongs to a class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. HEATHER M ROWE M.D. provides transparency into local medical care patterns within Virginia Beach, VA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Psychiatry** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.